Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Clinical features of Kaposi's sarcoma in Croatian renal transplant recipients. (CROSBI ID 159850)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bubic-Filipi, Ljubica ; Bašić-Jukić, Nikolina, Pasini, Josip, Kastelan, Željko ; Kes, Petar. Clinical features of Kaposi's sarcoma in Croatian renal transplant recipients. // Prilozi - Makedonska akademija na naukite i umetnostite. Oddelenie za biološki i medicinski nauki, 30 (2009), 175-84

Podaci o odgovornosti

Bubic-Filipi, Ljubica ; Bašić-Jukić, Nikolina, Pasini, Josip, Kastelan, Željko ; Kes, Petar.

engleski

Clinical features of Kaposi's sarcoma in Croatian renal transplant recipients.

To investigate the prevalence, clinical manifestations and outcome of Kaposi's sarcoma in Croatian renal transplant recipients. Methods: The Department database was retrospectively analysed according to clinical presentation, immunosuppressive protocol, treatment, and outcome of patients with Kaposi's sarcoma. Results: Kaposi's sarcoma occurred in four male patients (0.67% of all renal transplant recipients), with the onset of clinical presentation at 4 to 18 months of transplantation. HLA-B35 was present in all patients, whereas HLA-A2, -DR3 and -DR5 were present in three patients each. In all patients, the disease manifested with purple or bluish papules on the skin, without visceral organ or lymph node involvement. Immunosuppression was rapidly reduced in the first patient who rejected the graft. Three patients achieved complete remission upon reduction of immunosuppressive therapy and local irradiation, with preserved renal function. Conclusion: Kaposi's sarcoma is rare in Croatian renal transplant recipients. It tends to occur in male patients, soon after transplantation and is associated with HLA-B35. Reduction of immunosuppression is recommended as the first choice method in patients with skin-limited disease, accompanied by radiotherapy in resistant cases. Key words: Kaposi's sarcoma, kidney transplantation, tumour, immunosuppression.

Kaposi's sarcoma; renal transplantation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

30

2009.

175-84

objavljeno

0351-3254

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost